Your session is about to expire
← Back to Search
Magnetic Lymph Node Mapping for Stomach Cancer
Study Summary
This trial is testing a new way to find cancer spread in the lymph nodes of people with gastric cancer. They will be using a magnetic tracer and a fluorescent dye. If it is effective, this could help researchers better detect the disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I have been diagnosed with stomach cancer.I am using birth control during the study.I have an iron overload disorder.I cannot undergo surgery or receive additional treatment after surgery.I have gastric cancer confirmed by biopsy and am having surgery to remove it.My cancer has not spread to distant parts of my body.My stomach cancer is 4 cm or smaller, as measured before treatment.
- Group 1: Cohort II (intraoperative)
- Group 2: Cohort I (preoperative injection)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently engaged in this clinical experiment?
"At this time, registration for the trial has been closed. The protocol was initially posted on October 1st 2022 and last amended in September of that same year. If you are seeking alternative studies to participate in, 1174 clinical trials connected to gastric cancer and 30 Iron Conjugated Polymer in Saline Suspension programs currently need participants."
Are recruitment efforts still underway for this research?
"Unfortunately, this clinical trial has ceased taking enrolments as of September 1st 2022. At present, 1174 studies are recruiting for patients with gastric cancer and another 30 trials require participants to test Iron Conjugated Polymers in Saline Suspension."
How perilous is Iron Conjugated Polymer in Saline Suspension for patient consumption?
"Considering the limited data on efficacy and safety, Iron Conjugated Polymers in Saline Suspension is assigned a score of 1. This assessment comes from our team at Power since this is only a Phase 1 trial."
Share this study with friends
Copy Link
Messenger